Tibet Weixinkang Medicine Co., Ltd. (SHA:603676)
China
· Delayed Price · Currency is CNY 11.04
+0.24 (2.22%)
At close: Mar 10, 2026
Tibet Weixinkang Medicine Market Cap
Tibet Weixinkang Medicine has a market cap or net worth of 4.77 billion as of March 10, 2026. Its market cap has increased by 10.34% in one year.
Market Cap
4.77B
Enterprise Value
3.76B
Revenue
1.17B
Ranking
n/a
PE Ratio
21.30
Stock Price
11.04
Market Cap Chart
Since July 21, 2017, Tibet Weixinkang Medicine's market cap has increased from 3.37B to 4.77B, an increase of 41.75%. That is a compound annual growth rate of 4.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yabao Pharmaceutical Group | 4.60B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 4.75B |
| Jinling Pharmaceutical Company | 4.59B |
| Jinhe Biotechnology CO., LTD. | 4.58B |
| Shanghai Jiaoda Onlly Co.,Ltd | 4.56B |
| Tianjin Tianyao Pharmaceuticals | 4.56B |
| LanZhou Foci Pharmaceutical | 4.55B |
| Newland Pharmaceutical | 4.83B |